Immediate test results and patient treatment reduces the likelihood of a readmission “within 30 days of discharge” that could result in hospital penalties under Accountable Care.
“Consolidates and replaces a suitcase full of readers with a single device, that adapts to existing and FDA Cleared Point of Care tests, eliminates transportation of patient samples to central labs by testing the patient wherever they are, and transmits test results directly to The Cloud. The device that finally makes Point of Care diagnostics practical for healthcare providers."
SimpleTest™ by iAssay will be closing our Wefunder campaign in 2 weeks. Your chance to get in on the ground floor of this revolutionary healthcare device is coming to a close. www.WeFunder.com/iAssay .iAssay, a pioneer in medical device technology, has developed a patented diagnostic tool, SimpleTest™, that has already begun to revolutionize the Healthcare industry through Point […]
Thank you to everyone who attended our Investor Webinar. This was a great opportunity to meet more of the iAssay team, hear about some of our recent highlights and have your questions answered. If you were unable to join we don’t want you to miss out! As a supporter of iAssay, we are pleased to […]
SimpleTest™ by iAssay is the only universal, portable medical test reader on the market, and is poised to radically improve patient health. At our upcoming webinar, iAssay will be presenting an in-depth look at how SimpleTest™ has already begun to revolutionize the $26 Billion Medical Testing industry and the $65 Billion Healthcare Big Data industry. […]
We are so excited to be a part of an exclusive group of companies who have been named a COOL Company for the 2nd consecutive year. The COOL Companies list identifies San Diego’s fastest growing and most exciting companies; put together by Connect, which pairs tech and life science companies with quality capital and mentorship. […]
We are pleased to announce that SimpleTest™ by iAssay has over 100 investors. This is an incredible achievement for us as a company and we want to thank everyone who believes in our mission. It is thanks to you that we will be able to revolutionize the healthcare industry and help millions of people to […]
Innovative Program Aims to Improve Medical Testing Capabilities San Diego, CA 04/29/2021- iAssay announced this week that they have been awarded a Phase 1 SBIR (Small Business Innovation Research) Award through AFWERX. iAssay makes a patent-protected medical device called SimpleTest™ that can interpret test results and transmit preserved imaging and quantitative results electronically from point of […]
Thanks to you, our amazing investors and supporters, we’ve completed our first WeFunder milestone, closing the early bird $200,000 investment stage on Wefunder.com/iAssay.We want to thank this entire amazing community for helping us reach this goal and for believing in what we are committed to do.We have exciting client announcements and major partnerships coming down […]
Meet Paul F. Rashid, MD, our new Advisory Board Member and investor. We are so fortunate to have him aboard! iAssay has an EarlyBird investment special for a short time. Visit the site for more details: www.WeFunder.com/iAssay
For Release March 8, 2021 iAssay and DDTD Tag Team Against COVID-19 San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served […]